Investment
Features
FeesSafety
Academy
More
Pluang+

RMX Industries completes Vigilant Horizon session showcasing QuantrusX™ edge intelligence in real-world conditions

Market News
29 Sep 2026
PRNewsWire
View Source
Bullish
RMX Industries completes Vigilant Horizon session showcasing QuantrusX™ edge intelligence in real-world conditions

RMX Industries held Vigilant Horizon, a closed working session at a Texas ranch, demonstrating its QuantrusX™ edge intelligence platform in real operational settings. The event focused on Real-World Intelligence, emphasizing intelligence built and used directly at physical sites to support timely, informed decisions. Participants, including law enforcement, experienced how QuantrusX™ delivers actionable insights on-site, proving its value beyond traditional tech demos. RMX aims to continue refining its platform by testing it under real conditions with actual operators to ensure practical effectiveness.

RMX Industries' Vigilant Horizon working session in Texas is presented here alongside Pluang's Technology sector market data as of Sep 29, 2026 19:02 WIB. Out of 150 priced US tech stocks, 90 rose and 53 fell. Among notable movers, IREN traded at USD 42.54 with a 1-day change of +1.97% and a typical hold time of 26 days, while APLD was priced at USD 25.01, gaining +1.96% with 100% buy order activity, contrasting with IONQ at USD 45.44, up +1.93% and 67% buy orders, showing varied investor engagement across these assets.

More News

CarMax Q2 earnings jump 81% as used car sales and financing income rise

CarMax Q2 earnings jump 81% as used car sales and financing income rise

CarMax reported an 81.3% increase in second-quarter diluted earnings per share to $1.16, driven by a 13.8% rise in retail used vehicle sales and a 32.1% increase in auto finance income. Despite pricing actions that lowered gross profit per vehicle by...

Company Fundamentals
Bullish
4 hours ago
Medicus Pharma files streamlined Phase 2b/3 trial for prostate cancer drug Teverelix with FDA

Medicus Pharma files streamlined Phase 2b/3 trial for prostate cancer drug Teverelix with FDA

Medicus Pharma has submitted a streamlined Phase 2b/3 trial design to the FDA for Teverelix, a long-acting GnRH antagonist targeting advanced prostate cancer patients at increased cardiovascular risk. The new trial design combines dose optimization, ...

Market News
Bullish
4 hours ago
10-year Treasury yield nears 2007 peak amid Fed hikes, energy crisis, and rising US debt.

10-year Treasury yield nears 2007 peak amid Fed hikes, energy crisis, and rising US debt.

The 10-year US Treasury yield closed at 5.24% on September 28, 2026, just two basis points below its June 2007 peak of 5.26%, driven by expected Federal Reserve rate hikes, an energy crisis linked to the Iran war, ballooning US government debt, and i...

Market News
Bearish
4 hours ago
Metallus wins $995M contract to supply steel for U.S. Defense Logistics Agency over five years.

Metallus wins $995M contract to supply steel for U.S. Defense Logistics Agency over five years.

Metallus, a specialty metals producer, secured a five-year IDIQ contract with the U.S. Defense Logistics Agency valued up to $995 million to supply steel for critical defense uses. The contract includes an initial $125 million delivery order, with Me...

Market News
Bullish
4 hours ago
Anthropic plans $2T AI IPO amid soaring revenue but massive losses raise investor caution

Anthropic plans $2T AI IPO amid soaring revenue but massive losses raise investor caution

Anthropic is preparing for an IPO with a record $2 trillion valuation, aiming to be the first pure AI company on the market. Despite a massive revenue surge of over 1,000% from 2024 to 2025, the company reported a $42 billion loss, including a $34 bi...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App